CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.

about

CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.

Item

http://www.wikidata.org/entity/Q47309024

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CYP2D6 drug-gene and drug-drug ...... enetically actionable opioids.

@en

CYP2D6 drug-gene and drug-drug ...... enetically actionable opioids.

@nl

type

Item

label

CYP2D6 drug-gene and drug-drug ...... enetically actionable opioids.

@en

CYP2D6 drug-gene and drug-drug ...... enetically actionable opioids.

@nl

prefLabel

CYP2D6 drug-gene and drug-drug ...... enetically actionable opioids.

@en

CYP2D6 drug-gene and drug-drug ...... enetically actionable opioids.

@nl

P1476

CYP2D6 drug-gene and drug-drug ...... enetically actionable opioids.

@en

P2093

Ann M Holmes

http://www.w3.org/2001/XMLSchema#string

Marion E Broome

http://www.w3.org/2001/XMLSchema#string

Mitchell R Knisely

http://www.w3.org/2001/XMLSchema#string

Todd Skaar

http://www.w3.org/2001/XMLSchema#string

P2860

Data quality control in genetic case-control association studies.

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

Prerequisites to implementing a pharmacogenomics program in a large health-care system

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.

CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer.

Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues

Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.

How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.

Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing.

P304

107-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.APNR.2017.10.001

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Janet S. Carpenter

Claire Burke Draucker

Diane Von Ah

P577

2017-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29241501

http://www.w3.org/2001/XMLSchema#string

P921

opioid

P932

5734108

http://www.w3.org/2001/XMLSchema#string